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Abstract
Background: Amnioreduction remains a treatment option for pregnancies with twin-to-twin transfusion syndrome
(TTTS) not meeting criteria for laser surgery or those in which it is not feasible. Amnioreduction is a relatively
simple treatment which does not require sophisticated technical equipment. Previous reports of conservative
management have indicated that major neurodevelopmental impairment occurs in 14.3-26% of survivors. The
purpose of this study was to investigate long-term neurodevelopmental outcome in conservatively treated TTTS.
Methods: During the nine-year study period from January 1996 to December 2004, all pregnancies with TTTS who
were admitted to our center were investigated. TTTS was diagnosed by using standard prenatal ultrasound criteria,
and staged according to the criteria of Quintero et al. We reviewed gestational age at diagnosis, gestational age at
delivery, the stage of TTTS at diagnosis, and diagnosis to delivery interval. Neonatal cranial ultrasound findings
were reviewed and the neurodevelopmental outcomes were evaluated.
Results: Twenty-one pregnancies with TTTS were included. Thirteen pregnancies (62%) were treated with serial
amnioreduction. The mean gestational age at delivery was 28 weeks (22 - 34 weeks). The perinatal mortality rate
was 42.9%. Twenty survivors were followed up until at least 3 years of age. The mean age at follow-up was
6.3 years (3 - 12 years). Six children (30%) had neurodevelopmental impairment. Four children (20%) had major
neurodevelopmental impairment and two children (10%) had minor neurodevelopmental impairment. Children
with neurodevelopmental impairment were delivered before 29 weeks of gestation.
Conclusions: Our study showed a high rate of perinatal mortality and a high rate of major neurodevelopmental
impairment in conservatively treated TTTS. The long-term outcomes for the survivors with TTTS were good when
survivors were delivered after 29 weeks of gestation.
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Background
Twin-to-twin transfusion syndrome (TTTS) complicates
9% of monochorionic twin pregnancies, and if untreated,
is associated with a perinatal loss rate of over 80% [1,2].
Fetal interventions, such as repeated serial amnioreduc-
tion and laser surgery may reduce the perinatal mortal-
ity rate. A recent meta analysis has shown that the
overall survival rate varies from 57% to 77% following
laser surgery and from 38% to 81% following serial
amnioreduction [3].
The first randomized trial comparing amnioreduction
with endoscopic laser surgery showed that endoscopic
laser surgery resulted in higher survival rates and lower
rates of neurologic complications at six months of age
than did serial amnioreduction in severe TTTS present-
ing before 26 weeks of gestation. Therefore, endoscopic
laser surgery has been adopted as the first-line treatment
for TTTS diagnosed before 26 weeks [4]. As this techni-
que interrupts placental vascular communication, it can
potentially reduce neurodevelopmental impairment.
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dence of neurodevelopmental impairment in TTTS survi-
vors treated with laser surgery is still high [5,6].
Although amnioreduction is no longer the only treat-
ment option for TTTS, a subset of patients may still
benefit from this intervention. Amnioreduction is useful
in the setting of TTTS not meeting criteria for laser sur-
gery and in patients in whom laser surgery is not techni-
cally possible. Amnioreduction is a relatively simple
treatment which does not require sophisticated technical
equipment. Previous reports of conservative manage-
ment have indicated that major neurodevelopmental
impairment occurs in 14.3%- 26% of survivors [7-10].
This study was undertaken to investigate the long-
term neurodevelopmental outcome in conservatively
treated TTTS.
Methods
We examined the prenatal records of all women and the
medical records of children and neonates with TTTS
admitted to the Maternity and Perinatal Care Unit of
Kyushu University Hospital from January 1996 to
December 2004. TTTS was diagnosed in all cases by
ultrasound criteria of polyhydramnios (> 8 cm, deepest
vertical pool) in one twin sac and oligohydramnios
(‹2 cm, deepest vertical pool) in the co-twin of a mono-
chorionic, diamniotic pregnancy [11]. In our hospital,
laser surgery was not performed, so cases with laser sur-
gery were not included.
The following data were obtained from the maternal
medical record: gestational age at diagnosis, gestational
age at delivery, the stage of TTTS at diagnosis, diagnosis
to delivery interval, and amnioreduction. TTTS was
staged according to the criteria of Quintero et al. [12].
The following neonatal data were extracted: birth weight
and cranial ultrasound findings. Cranial ultrasound
scans were obtained in all neonates shortly after birth
and further scans were carried out one, three, five, and
seven days after birth, followed by weekly scans there-
after until discharge. Additional scanning was underta-
ken as clinically indicated. Abnormal cranial ultrasound
findings in the neonatal period were reviewed for the
presence of intraventricular hemorrhage (IVH), periven-
tricular leukomalacia (PVL), and ventricular dilatation.
Intraventricular hemorrhage (IVH) was classified
according to Papile et al. [13]. Periventricular leukoma-
lacia (PVL) was graded according to Vries et al. [14].
Severe cerebral lesions on cranial ultrasound findings
were defined as the presence of IVH grade III or IV,
and/or PVL ≥ grade II.
All surviving children were offered care in our high-
risk infant follow-up program. Repetitive examinations
by experienced pediatric neurologists were performed.
Their development was evaluated using the Enjoji
Developmental Scale [15] before six years of age, fol-
lowed by the Japanese Wechsler Intelligence Scale for
Children-Revised [16] (WISC-R) or Wechsler Preschool
Primary Scale of Intelligence at six years or older [17]
(WPPSI). Children with normal development had a nor-
mal neurological evaluation and developmental quotient
(DQ) or intellectual quotient (IQ) > 85. Minor neurode-
velopmental impairment was defined as the presence of
at least one of the following: mild cerebral palsy causing
motor clumsiness or non-fluent gait, DQ or IQ between
70 and 85. Major neurodevelopmental impairment was
defined as the presence of at least one of the following:
cerebral palsy, DQ or IQ < 70, deafness, or blindness.
Cerebral palsy was classified as diplegia, hemiplegia,
quadriplegia, dyskinetic or mixed [6,8]. Developmental
or mental borderline was defined as DQ or IQ between
70 and 85. Developmental or mental retardation was
defined as DQ or IQ < 70 [15-17].
Statistical analysis
Analysis was performed with the SPSS statistical pack-
age 16.0 (SPSS Inc, Chicago, IL). Differences between
categorical variables were analyzed using the chi-square
test or the Fisher exact test as appropriate. Differences
between continuous variables were tested using inde-
pendent sample t-tests. A statistically significant differ-
ence was defined as p < 0.05.
Ethical considerations
Ethical permission was obtained, based on the criteria of
t h eK y u s h uU n i v e r s i t yr e s e a rch ethics committee con-
cerning observational studies.
Results
Table 1 shows the pregnancy and fetal outcomes with
TTTS. During the nine-year study, 21 pregnancies with
TTTS were admitted to our center. The gestational age
at diagnosis ranged from 18 to 34 weeks with a mean
age of 24 weeks. The gestational age at delivery ranged
from 22 to 34 weeks with a mean age of 28 weeks. Thir-
teen pregnancies (61.9%) were treated with serial
amnioreduction, with the number of amniocenteses ran-
ging from one to six per pregnancy (mean 2.7). In the
eight pregnancies in which amnioreduction was not per-
formed, one pregnancy was complicated by premature
rupture of the membrane, two pregnancies presented
with mild TTTS (stage I), and one pregnancy opted for
delivery. There were two survivors in 42.9% of pregnan-
cies, one survivor in 19% of pregnancies, and no survi-
vors in 38.1% of the pregnancies. The Quintero stage at
diagnosis showed 11 pregnancies to be stage I, four
pregnancies to be stage II, three pregnancies to be stage
III, three pregnancies to be stage IV, and none to be
stage V. Intrauterine fetal demise occurred in five
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Page 2 of 7fetuses (11.9%), and all of these resulted from pregnan-
cies not treated with amnioreduction. One pregnancy
culminated in the intrauterine death of both fetuses, and
three pregnancies resulted in the intrauterine death of
one fetus. In the three neonates born after the intrauter-
ine fetal demise of their co-twin, one neonate born at
22.4 weeks died soon after birth, one neonate died of
heart failure at 75 days of age, and one survivor had
mild cerebral palsy with epilepsy and mental retardation.
Neonatal death occurred in 13 neonates (35.1%). The
overall perinatal mortality rate was 42.9% (18/42). Two
infants died after the neonatal period. Twenty-two survi-
vors were followed to at least the age of 1 year corrected
for prematurity. Two survivors were lost to follow-up
after the age of one year. Neurological follow-up was
available for the remaining twenty survivors. The mean
age at follow-up was 6.3 years (range, 3-12 years). Four-
teen children (70%) had normal neurological develop-
ment. Six children (30%) had neurodevelopmental
impairment.
Of 37 neonates, four died before the cranial ultra-
sound scan was performed. Abnormal ultrasound find-
ings were present in seventeen (51.5%) of 33 neonates
as follows: IVH grade I in five neonates; IVH grade І in
three neonates; IVH grade I + III in two neonates; PVL
grade I in three neonates; PVL grade І in two neonates;
and mild ventricular dilatation in two neonates. Of
seventeen neonates with abnormal cranial ultrasound
findings, neonatal death occurred in five neonates; infant
death occurred in two infants; one survivor was lost to
follow-up; five of the nine survivors had neurodevelop-
mental impairment. A severe cerebral lesion was present
in four neonates (12.1%). One neonate born at 24 weeks
died of heart failure at one day of age. One neonate
whose co-twin died at 26 weeks of gestation died of
heart failure at 75 days of age. Two survivors had major
neurodevelopmental impairment. On 16 neonates with
normal cranial ultrasound findings, neonatal death
occurred in four neonates; one survivor was lost to fol-
low-up; and one survivor had minor neurodevelopmen-
tal impairment.
Table 2 shows adverse neurodevelopmental outcomes
with TTTS. Four children (20%) had major neurodeve-
lopmental impairment. For case 1 (in which fetal death
of the donor co-twin occurred at 25 weeks of gestation),
birth occurred at 27 weeks of gestation. The child was
found to have mental retardation (IQ 61) and epilepsy
with mild cerebral palsy causing a non-fluent gait. Case
2( P V L( g r a d eІ)) had mental retardation (IQ 69). Case
3 had mild bilateral ventricular dilatation and mental
retardation (IQ 54). Case 4 had posthemorrhagic hydro-
cephalus and mild cerebral palsy causing motor clumsi-
ness. Because the child’s IQ was exactly 70, the case was
classified as borderline mental impairment. However, we
considered case 4 to have major neurodevelopmental
impairment in this study on the basis of general clinical
judgment.
Two children (10%) had minor neurodevelopmental
impairment. Case 5 had borderline mental impairment
(IQ 78) and mild cerebral palsy causing motor clumsi-
ness while case 6 had borderline mental impairment
only (IQ 71). Case 2/case 6 and case 4/case 5 comprised
the pairs in two twin pregnancies. All of them were
delivered before 29 weeks of gestation.
Table 3 shows antenatal and delivery characteristics in
surviving cases without neurodevelopmental complications
as well as those complicated by death or neurodevelop-
mental impairment. The mean gestational age for those
surviving without complication at diagnosis and delivery
was 28 weeks (range, 24 - 34 weeks) and 31 weeks (range,
27-34 weeks), respectively and the mean gestational age
for those with death or neurodevelopmental impairment
at diagnosis and delivery was 22 weeks (range, 19 - 27
weeks) and 27 weeks (range, 22 - 31 weeks), respectively.
Table 1 Antenatal and delivery characteristics
Pregnancies(n) 21
Age (years) 28 (20-38)
Parity 0 (0-3)
Gestational age at diagnosis(weeks) 24 (18-34)
Gestational age at delivery(weeks) 28 (22-34)
Diagnosis to delivery interval(days) 25 (1-73)
Use of amnioreduction 13 (61.9%)
Amnioreduction per pregnancy 2.7 (1-6)
Cesarean section 13 (61.9%)
Gestational age < 30 weeks at delivery 15 (71.4%)
Quintero stage I 11 (52.4%)
Quintero stage II 4 (19%)
Quintero stage III 3 (14.3%)
Quintero stage IV 3 (14.3%)
Quintero stage V 0
IUFD of 1 twin 3 (14.3%)
IUFD of both twins 1 (4.8%)
0 survivor* 8 (38.1%)
1 survivor 4 (19%)
2 survivors 9 (42.9%)
Fetus(n) 42
Intrauterine fetal death (IUFD) 5 (11.9%)
Neonatal death 13 (35.1%)
Overall perinatal mortality 18 (42.9%)
Infant death 2 (5.4%)
Lost to follow-up 2 (5.4%)
Long-term survivors 20 (54.1%)
neurodevelopmental impairment 6 (30%)
Data shown as mean (range) or n (%) as appropriate.
*Survivor is defined as the survival of at least 12 months of age.
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neurodevelopmental impairment was lower than surviving
cases without neurodevelopmental impairment. The inter-
val between diagnosis and delivery was significantly longer
and the birth weight was significantly lower in those com-
plicated by death or neurodevelopmental impairment.
There was no difference in the ratio of Donors to Recipi-
ents between the groups.
Table 4 shows perinatal outcomes and survivors’ out-
comes between amnioreduction and non-amnioreduc-
tion. There was no significant difference in the mean
gestational age at delivery, diagnosis to delivery interval,
or neurodevelopmental impairment.
Discussion
In this study, we reported that the overall perinatal mor-
tality rate in conservatively treated patients with TTTS
was 42.9%. The result was similar to the mortality
reported by Mari et al. [18], Gray et al.[ 1 9 ] ,a n dS e n a t
et al. [4].
We found that 30% of surviving twins had neurodeve-
lopmental impairment when TTTS was treated conser-
vatively. Four children (20%) had major
neurodevelopmental impairment. Two children (10%)
had minor neurodevelopmental impairment. Cincotta et
al. observed 17 pregnancies, of which 12 (71%) were
treated with serial amnioreduction [9]. Twenty-three
children were followed up at least two years. Five survi-
vors (22%) had major neurological morbidity, which was
similar to our results. Dickinson et al. [7] investigated
52 surviving infants from 31 pregnancies, with 22 preg-
nancies treated with serial amnioreduction. 49 children
were followed up at a median age of five years. Major
neurodevelopmental disability was present in seven chil-
dren (14.3%). Minor neurodevelopmental impairment
was not reported. Mari et al. investigated 42 survivors of
Table 2 Data of the 6 surviving twins with adverse neurodevelopmental outcomes
Case D/
R
Quintero
stage
GA
at
diagnosis
(weeks)
GA
at
birth
(weeks)
AR
(n)
Birth
weight
(g)
Neonatal
cranial
ultrasound
findings
Follow-
up
age
(years)
Neurodevelopmental
Impairment
IQ Outcome of
co-twin
Severity
1 R III 19 27 0 814 IVH I 6 Mild CP, epilepsy,
Mental retardation
61(6
years)
IUFD major
2 R I 20 28 4 1018 PVL І 8 Mental retardation 69(6
years)
mental
borderline
major
3 R II 26 27 1 1130 mild bilateral
ventricular
dilatation
7 Mental retardation 54(6
years)
Infant death
major
4 D I 21 28 0 865 IVH III 12 Mild CP,
mental borderline
hydrocephalus
70(12
years)
Mild CP,
mental
borderline
major
5 R I 21 28 0 975 IVH I 12 Mild CP,
Mental borderline
78(12
years)
Mild CP,
mental
borderline,
hydrocephalus
minor
6 D I 20 28 4 886 normal 8 Mental borderline 71(6
years)
mental
retardation
minor
R = Recipient, D = Donor, GA = Gestational age, AR = Amnioreductions.
IVH = Intraventricular hemorrhage, PVL = periventricular leukomalacia; CP = cerebral palsy.
IUFD = intrauterine fetal death, IQ = intellectual quotient.
Table 3 Comparison of normal development and death or neurodevelopmental impairment
Normal development Death or Neurodevelopmental impairment P value
Number 14 26
Gestational age at diagnosis
(weeks)
28 (24-34) 22 (19-27) < 0.001
Gestational age at delivery
(weeks)
31 (27-34) 27 (22-31) < 0.001
Diagnosis to delivery interval
(days)
15 (2-34) 32 (1-50) 0.002
Birth weight
(g)
1355 (750-2130) 812 (255-1970) 0.001
Donor/Recipient 7/7 13/13 0.999
Data shown as mean (range) or n as appropriate.
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palsy was diagnosed in two of 42 infants (4.7%). No
developmental tests were used and the incidence of
major neurodevelopmental impairment was lower. With
regard to overall neurodevelopmental impairment, we
found the incidence was lower than several studies pre-
viously reported in analyses of long-term neurological
outcome [8,10,21]. Lopriore et al. investigated 29 preg-
nancies, including 18 pregnancies (62%) with serial
amnioreduction [10]. Twenty-nine children were fol-
lowed up to a mean age of 6.2 years (4-11). Major neu-
rodevelopmental impairment was observed in 21% of
children, and minor neurodevelopmental impairment
(mild speech delay) was seen in 17.2% (5/29). Haver-
kamp et al. described 40 children who were followed up
to a mean age of 24 months [21]. Major neurodevelop-
mental impairment was seen in 23%, while minor neu-
rodevelopmental impairment was found in 33%. Frusca
et al. investigated 31 children who were followed up to
a mean age of 24 months [8]. Eight children (25.8%) had
major neurologic disabilities; five children (16.1%) had
minor neurologic disabilities. This discrepancy may be
due to the heterogeneity within the neurodevelopmental
impairment of TTTS and assessment of neurodevelop-
mental outcome.
Abnormal cranial ultrasound findings were found in
seventeen cases (51.5%) of the 33 neonates who under-
went cranial ultrasound scans. Denbow et al.r e p o r t e d
an even higher incidence (58%) of neonates with abnor-
mal cranial ultrasound findings [2]. Gestational age at
delivery and birth weight were not associated with an
incidence of abnormal cranial ultrasound findings. Cra-
nial ultrasound scans at birth are commonly used as a
surrogate marker for neurodevelopmental outcome in
later life [22]. Periventricular white matter lesions
(WMLs) and persistent ventriculomegaly in particular
have been associated with an adverse neurodevelopmen-
tal outcome [22,23]. In our patient group, five cases
(15.2%) showed WMLs. Some studies have shown evi-
dence of cerebral white matter lesions in one third of
monochorionic twin infants at birth, particularly when
the pregnancy was complicated by long-term coexis-
tence with a co-twin intrauterine demise [24,25]. Hecher
et al. [26] reported a lower incidence (6%) of cerebral
WMLs following laser surgery, compared with the cases
treated by amnioreduction (18%). Results from observa-
tional studies [2,10,27] and an international multicenter
registry [18,28] of TTTS treated by amnioreduction sug-
gest that the incidence of major cranial abnormalities
ranges between 18 and 41%. Discrepancies among
results may be due to differences in diagnostic criteria,
disease onset, severity of the TTTS, treatment modal-
ities, and stratification of cranial lesions.
Since laser surgery for TTTS was introduced, survival
rates have been increasing. Neurodevelopmental impair-
ment, however, is still relatively common. Sutcliffe et al.
investigated 67 children with severe TTTS treated by
laser surgery, and 9% had cerebral palsy [29]. They did
not report the number of infants with developmental
delay. Banek et al. investigated 89 children after TTTS
treated by laser surgery between 14 months and 44
months. Eleven percent of the children had minor neu-
rologic deficiencies, and an equal portion had major
neurologic deficiencies [5]. Graef et al. investigated 167
children from TTTS treated by laser surgery and fol-
lowed to a median age of 38 months (14 - 53) [30]. In
this group, 7.2% of the children showed minor neurolo-
gic abnormalities, and 6% showed major neurologic
abnormalities. Both studies originated from the same
research group in Germany. The largest analysis con-
cerning long-term neurodevelopmental outcome after
TTTS with laser surgery was published by Lopriore et
al. [6]. They investigated 278 children at two years of
age (corrected for prematurity). The incidence of major
neurodevelopmental impairment was 18%. They did not
report minor neurodevelopmental impairment.
Whether TTTS is treated with laser surgery or mana-
ged conservatively, the incidence of major neurodevelop-
mental impairment is high. The pathogenesis of cerebral
injury in TTTS is not clearly defined. Cerebral injury in
TTTS may result from antenatal injury secondary to
hemodynamic and hematological imbalance [21] and/or
from postnatal injury associated with prematurity [31]
and low birth weight [8]. In our study, the long-term
outcomes for the survivors with TTTS were relatively
Table 4 Perinatal outcomes and survivor’ outcomes
between amnioreduction (AR) and non-amnioreduction
(non-AR)
AR non-AR P
value
Number 26 16 NS
Gestational age at diagnosis
(weeks)
25 (18-32) 23 (19-34) NS
Gestational age at delivery
(weeks)
28 (24-34) 27 (22-34) NS
Diagnosis to delivery interval
(days)
22 (4-56) 30 (1-73) NS
Birth weight (g) 1124 (335-
2222)
921 (255-
2138)
NS
IUFD 0 5 (31.2%) NS
Neonatal death 10 (38.5%) 3 (27.3%) NS
Infant death 1 (3.8%) 1 (9.1%) NS
Lost to follow-up 2 (7.7%) 0 NS
Long-term survivors 13 (50%) 7 (63.6%) NS
Neurodevelopmental
impairment
3 (23.1%) 3 (42.9%) NS
Data shown as mean (range) or n (%) as appropriate.
NS, not significant; IUFD, intrauterine fetal death.
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gestation. Mari et al. found that long-term outcomes for
the twins with TTTS were excellent when both fetuses
were delivered alive after 27 weeks of gestation [20]. A
research group from Germany reported that neurodeve-
lopmental disability in infants who were born before 32
weeks of gestation was significantly higher [5,30].
Lopriore et al. and Lenclen et al. showed that early
gestational age at delivery was a risk factor for neurode-
velopmental impairment [6,32]. It seems that prolonga-
tion of gestation is central in management strategies.
T h er e s u l t so ft h ep r e s e n ts t u d ys u g g e s tt h a tt h eo u t -
comes, particularly neurodevelopmental, resulting from
the conservative management of TTTS are not markedly
different from outcomes obtained with laser surgery.
The strength of our conclusion is limited by the small
study size and the preponderance of mild cases which
presented later[6]. While immediate neonatal survival
may be improved with laser surgery, this advantage may
be lost with long term follow-up.
Conclusions
In conclusion, the primary predictor for neurodevelop-
mental impairment is gestational age, regardless of
whether the management is conservative or by laser sur-
gery. Therefore, prolongation of gestation is important.
Additionally, we suggest performing a routine cranial
ultrasound examination after birth as the results will be
valuable in predicting long-term neurodevelopmental
outcomes.
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